Oric Pharmaceuticals (ORIC) Earnings Date & Reports
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ORIC is expected to report earnings to rise 18.52% to -39 cents per share on March 24
Q4'25
Est.
$-0.39
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of -33 cents, beating the estimate of -40 cents. With 1.40M shares outstanding, the current market capitalization sits at 1.13B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ORIC showed earnings on November 13, 2025. You can read more about the earnings report here.